About Jinlin

Professor Jinlin Hou is the Director and Professor of the Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Professor Hou is the president of APASL 2017 and the president of Chinese Medical Association of Infectious Diseases(2013-2016). Professor Hou joined the University Department of Medicine of Nanfang Hospital in July 1984. Between 1993 and 1994,he received training in the Department of Medicine at St. Mary’s Hospital Medical School in London, UK. Between 2000 and 2001, Professor Hou was a visiting Fellow at the Institute of Hepatology, London, UK. He has been invited to deliver talks at both national and international liver conferences owing to his expertise in viral hepatitis and other liver diseases. His current research interests include the clinical management of liver and Infectious Diseases and the molecular virology and immunology of hepatitis virus infection. He has published more than 500 articles in both national and international journals, including GUT, Hepatology, Journal of Immunology,Journal of Hepatology, Science,LANCET Infect Dis, NEJM et al.

This speaker will be presenting at the following session(s)

  • Prevention interventions

    Ballroom 3

    Day: 2 November

    Time: 14:00

    Chair: Dr. Amr Kandeel, Ministry of Health, Egypt and Dr. Mark Jacobs, World Health Organization


    • Viral hepatitis prevention efforts in Egypt – successes and challenges.
    • Dr. Amr Kandeel, Ministry of Health, Egypt
    • WHO Injection Safety Project.
    • Dr. Arshad Altaf, World Health Organization
    • Implementing injection safety at the country level: challenges and opportunities.
    • Dr. Huma Qureshi, Pakistan Health Research Council
    • Towards zero transmission of HBV from mother to child: new data and the SHIELD project.
    • Dr. Jinlin Hou, Nanfang Hospital, China
    • HCV prevention among people who use drugs: evidence and ways forward.
      Dr. Niklas Luhmann, Médecins du Monde
    • Blood safety and hepatitis.
    • Dr. Marcelo Addas-Carvalho, Blood Center of Campinas/UNICAMP
    • Q & A session.

    Session objectives:

    • Discuss different core areas of viral hepatitis prevention.
    • Hear country examples of good practice for health facility injection safety, vertical transmission and blood product safety.